Related Experiment Video
Updated: Jul 30, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Acute pancreatitis associated with omeprazole.
S S Youssef1, S B Iskandar, J Scruggs
1James H. Quillen Veterans Affairs and James H. Quillen College of Medicine, Johnson City, TN, USA.
Proton pump inhibitors (PPIs) effectively treat acid-related disorders. However, this case report details a rare instance of acute pancreatitis linked to omeprazole, a commonly used PPI.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Proton pump inhibitors (PPIs) are widely used for acid-peptic disorders, offering superior gastric acid suppression compared to H2-receptor blockers.
- PPIs are generally considered safe with minimal side effects and few drug interactions, making them suitable for long-term use.
- Established indications include gastroesophageal reflux disease, peptic ulcer disease, and NSAID-induced gastropathy.
Observation:
- This report describes a rare adverse event associated with PPI therapy.
- A patient developed acute pancreatitis during treatment with omeprazole.
Findings:
- Proton pump inhibitors (PPIs) demonstrate significant efficacy in managing acid-related gastrointestinal conditions.
- While generally safe, PPIs can rarely be associated with serious adverse events.
- Acute pancreatitis is identified as a potential, albeit uncommon, side effect of omeprazole.
Implications:
- Clinicians should be aware of rare but severe side effects associated with PPIs.
- Further investigation may be warranted to understand the mechanism linking PPIs to pancreatitis.
- This case highlights the importance of considering drug-induced causes in pancreatitis diagnosis.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction